Cooper Companies | COO - Current Assets

Stock Price
64.41
Daily Change
-0.54 -0.83%
Monthly
-9.85%
Yearly
-20.37%
Q2 Forecast
68.52

Cooper Companies reported $2.13B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Bausch Health Companies USD 6.16B 92M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Dentsply International USD 2.02B 49M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.74B 380M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
STAAR Surgical USD 311.54M 9.66M Dec/2025
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Utah Medical Products USD 97.74M 1.21M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025